Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Mediators Inflamm
2014 Jan 01;2014:872464. doi: 10.1155/2014/872464.
Show Gene links
Show Anatomy links
Predictive criteria to study the pathogenesis of malaria-associated ALI/ARDS in mice.
Ortolan LS
,
Sercundes MK
,
Barboza R
,
Debone D
,
Murillo O
,
Hagen SC
,
Russo M
,
D' Império Lima MR
,
Alvarez JM
,
Amaku M
,
Marinho CR
,
Epiphanio S
.
Abstract
Malaria-associated acute lung injury/acute respiratory distress syndrome (ALI/ARDS) often results in morbidity and mortality. Murine models to study malaria-associated ALI/ARDS have been described; we still lack a method of distinguishing which mice will develop ALI/ARDS before death. This work aimed to characterize malaria-associated ALI/ARDS in a murine model and to demonstrate the first method to predict whether mice are suffering from ALI/ARDS before death. DBA/2 mice infected with Plasmodium berghei ANKA developing ALI/ARDS or hyperparasitemia (HP) were compared using histopathology, PaO2 measurement, pulmonary X-ray, breathing capacity, lung permeability, and serum vascular endothelial growth factor (VEGF) levels according to either the day of death or the suggested predictive criteria. We proposed a model to predict malaria-associated ALI/ARDS using breathing patterns (enhanced pause and frequency respiration) and parasitemia as predictive criteria from mice whose cause of death was known to retrospectively diagnose the sacrificed mice as likely to die of ALI/ARDS as early as 7 days after infection. Using this method, we showed increased VEGF levels and increased lung permeability in mice predicted to die of ALI/ARDS. This proposed method for accurately identifying mice suffering from ALI/ARDS before death will enable the use of this model to study the pathogenesis of this disease.
Figure 1. Infection of DBA/2 mice with P. berghei ANKA constitutes a rodent model for malaria-associated ALI/ARDS. (a) Survival and (b) parasitemia curves from the ALI/ARDS and HP mice over time. The red line was the mice that died with ALI/ARDS. The gray area represents the period when the mice die of ALI/ARDS. The data presented are representative of 13 independent experiments; n = 10–12 mice/experiment. (c) The lungs of mice that died with ALI/ARDS weighed 40% more than the lungs of mice that died with HP (**P ≤ 0.005; Mann-Whitney test of lung weights are representative of four separate experiments). Data ((b) and (c)) represent means and SEM; n = 10–12 mice/experiment. (d) Representative pictures of a NI mouse, (e) an infected mouse that died with ALI/ARDS showing hemorrhagic lungs and a large amount of pleural effusion, and (f) a mouse that died with HP showing pale and grayish lungs and no pleural effusion. Representative histopathological images of lungs from (g) NI mice and infected DBA/2 mice that died with (h) ALI/ARDS and (i) HP on the 10th and 21st days after infection, respectively. The arrow points to the hyaline membranes in the lungs of the DBA/2 mice that died with (j) ALI/ARDS stained with hematoxylin-eosin and (k) stained with phosphotungstic acid hematoxylin. The bar corresponds to 100 μm. HP: hyperparasitemia; ALI/ARDS: acute lung injury/acute respiratory distress syndrome.
Figure 2. Radiography of the lungs, hypoxemia, and body temperature over time. (a) From left to right, X-rays from NI and infected DBA/2 mice that died with ALI/ARDS and HP showing different lung opacification scores on the 7th DAI. (b) Lung opacification scores on the 7th DAI. Mice that will later die with ALI/ARDS have a higher lung opacification score compared with mice that will die with HP (n = 12; *P ≤ 0.05, Mann-Whitney test of scores taken from two separate experiments). NI mice do not have any lung opacification and are assigned score zero. (c) PaO2/FiO2 values in P. berghei ANKA-infected mice on the 7th DAI. Results from three grouped experiments (n = 13 mice, *P ≤ 0.05; Mann-Whitney test). (d) Body temperatures in DBA/2 mice infected with P. berghei ANKA slightly increased on the 5th DAI from 37.1°C in the NI mice to 37.3 in the ALI/ARDS mice and 37.4°C in the HP mice). However, the temperatures dropped and the mice became hypothermic (especially the ALI/ARDS mice), with mean temperatures of 33.0°C on the 7th DAI and 32.8°C on the 9th DAI. Results are from three grouped experiments (n = 31 mice; ***P ≤ 0.001, two-way ANOVA with Bonferroni post test). Data (d) represents means and SEM. The dashed line represents the mean value of NI mice. NI: noninfected mice; ALI/ARDS: acute lung injury/acute respiratory distress syndrome; HP: hyperparasitemia.
Figure 3. Breathing patterns and parasitemia from ALI/ARDS and HP mice over time. (a) and (b) Breathing patterns and (c) parasitemia from DBA/2 mice infected with P. berghei ANKA that developed ALI/ARDS and HP over time. (a) There was no evidence on the 5th and 9th DAI that the ALI/ARDS and HP mice had different breathing patterns. However, on the 7th DAI, there was evidence that the ALI/ARDS mice had a higher enhanced pause (Penh) (a) and a lower respiratory frequency (b) than the HP mice. Parasitemia increased over time in both groups (c). Results are representative from three independent experiments (n = 11 mice/experiment; *P ≤ 0.05, two way ANOVA with Bonferroni post test). The dashed line represents the mean value of NI mice; NI: noninfected mice; ALI/ARDS: acute lung injury/acute respiratory distress syndrome; HP: hyperparasitemia.
Figure 4. Breathing patterns and parasitemia could be used to group mice into two main clusters. Ward's linkage cluster analysis illustrates the distance between the physiological cluster patterns in DBA/2 mice infected with P. berghei ANKA that developed ALI/ARDS and HP. Values were measured on the 7th DAI. The data are from 13 independent experiments; n = 142 mice. Group 1 = 88.46% of individuals with ALI/ARDS and 11.53% with HP; group 2 = 57.77% of individuals with ALI/ARDS and 42.22% with HP; group 3 = 19.35% individuals with ALI/ARDS and 80.64% with HP; group 4 = 21.42% of individuals with ALI/ARDS and 78.57% with HP. ALI/ARDS: acute lung injury/acute respiratory distress syndrome; HP: hyperparasitemia.
Figure 5. A murine model to predict malaria-associated ALI/ARDS. (a) Penh (enhanced pause), (b) respiratory frequency, and (c) parasitemia measured on the 7th DAI. The sacrificed mice were classified according predictive model, using the parameter cut-offs measured from the survival mice and applied to the sacrificed mice. DBA/2 mice infected with P. berghei ANKA and their breathing parameters were measured in plethysmograph chambers (BUXCO Electronics, USA). Note that these three parameters are similar between the survival group and sacrificed group; (n = 11 mice/group; *P < 0.05, **P < 0.005, Mann-Whitney test). ALI/ARDS: acute lung injury/acute respiratory distress syndrome; HP: hyperparasitemia; bpm: beats per minute. Results are representative of more than 5 independent experiments.
Figure 6. Increased vascular permeability and serum VEGF protein confirmed the predictive criteria for malaria-associated ALI/ARDS. (a) Serum VEGF protein in DBA/2 mice infected with P. berghei ANKA on the 7th DAI was measured by ELISA. The VEGF levels are higher in the mice classified as likely to die with ALI/ARDS compared with HP mice (according to the proposed predictive criteria). The data represent fold increases in relation to NI mice taken from three experiments; (n = 28 mice; **P < 0.005, Mann-Whitney test). (b) Lung vascular permeability in DBA/2 mice infected with P. berghei ANKA 7th DAI, assessed using Evans Blue. The vascular permeability is higher in the mice classified as likely to die with ALI/ARDS compared with the HP mice (according to the proposed predictive criteria). The data represent fold increased in relation to NI mice taken from three experiments; (n = 51 mice; *P < 0.05, Mann-Whitney test). Bars represent means and SEM. The images represent (c) NI: noninfected mice, (d) ALI/ARDS: acute lung injury acute respiratory distress syndrome, and (e) HP: hyperparasitemia.
Al-Ibrahim,
Bilateral pleural effusions with Plasmodium falciparum infection.
1975, Pubmed
Al-Ibrahim,
Bilateral pleural effusions with Plasmodium falciparum infection.
1975,
Pubmed
Antinori,
Biology of human malaria plasmodia including Plasmodium knowlesi.
2012,
Pubmed
Bastarache,
Development of animal models for the acute respiratory distress syndrome.
2009,
Pubmed
Bernard,
The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.
1994,
Pubmed
Ci,
Short-term roxithromycin treatment attenuates airway inflammation via MAPK/NF-κB activation in a mouse model of allergic asthma.
2012,
Pubmed
Clark,
Human malarial disease: a consequence of inflammatory cytokine release.
2006,
Pubmed
Cotovio,
Fibrin deposits and organ failure in newborn foals with severe septicemia.
2008,
Pubmed
Cross,
Plasmodium chabaudi chabaudi (AS): inflammatory cytokines and pathology in an erythrocytic-stage infection in mice.
1998,
Pubmed
Deroost,
Hemozoin induces lung inflammation and correlates with malaria-associated acute respiratory distress syndrome.
2013,
Pubmed
Epiphanio,
VEGF promotes malaria-associated acute lung injury in mice.
2010,
Pubmed
Favre,
Role of ICAM-1 (CD54) in the development of murine cerebral malaria.
1999,
Pubmed
Hamelmann,
Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography.
1997,
Pubmed
Harris,
Sequential Plasmodium chabaudi and Plasmodium berghei infections provide a novel model of severe malarial anemia.
2012,
Pubmed
Hasday,
Exposure to febrile temperature modifies endothelial cell response to tumor necrosis factor-alpha.
2001,
Pubmed
Hee,
Reduced activity of the epithelial sodium channel in malaria-induced pulmonary oedema in mice.
2011,
Pubmed
Hernandez-Valladares,
Comparison of pathology in susceptible A/J and resistant C57BL/6J mice after infection with different sub-strains of Plasmodium chabaudi.
2004,
Pubmed
Hernu,
An attempt to validate the modification of the American-European consensus definition of acute lung injury/acute respiratory distress syndrome by the Berlin definition in a university hospital.
2013,
Pubmed
Lacerda-Queiroz,
The role of platelet-activating factor receptor (PAFR) in lung pathology during experimental malaria.
2013,
Pubmed
Li,
Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain.
2003,
Pubmed
Lomask,
Further exploration of the Penh parameter.
2006,
Pubmed
Lovegrove,
Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model.
2008,
Pubmed
Luh,
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapies.
2007,
Pubmed
Mackintosh,
Clinical features and pathogenesis of severe malaria.
2004,
Pubmed
Matute-Bello,
An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals.
2011,
Pubmed
Matute-Bello,
Animal models of acute lung injury.
2008,
Pubmed
Miller,
The pathogenic basis of malaria.
2002,
Pubmed
Mohan,
Acute lung injury and acute respiratory distress syndrome in malaria.
2008,
Pubmed
Parker,
Evaluation of lung injury in rats and mice.
2004,
Pubmed
Piguet,
Role of CD40-CVD40L in mouse severe malaria.
2001,
Pubmed
Piguet,
Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice.
2000,
Pubmed
Ranieri,
Acute respiratory distress syndrome: the Berlin Definition.
2012,
Pubmed
Schmidt,
Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
2011,
Pubmed
Sciuto,
Temporal changes in respiratory dynamics in mice exposed to phosgene.
2002,
Pubmed
Senaldi,
Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria.
1994,
Pubmed
Sirivichayakul,
Pleural effusion in childhood falciparum malaria.
2000,
Pubmed
Souza,
Early and late acute lung injury and their association with distal organ damage in murine malaria.
2013,
Pubmed
Stark,
Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.
2005,
Pubmed
Taylor,
Respiratory manifestations of malaria.
2012,
Pubmed
Van den Steen,
Pathogenesis of malaria-associated acute respiratory distress syndrome.
2013,
Pubmed
Van den Steen,
Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome.
2010,
Pubmed
White,
Malaria.
2014,
Pubmed
White,
Plasmodium knowlesi: the fifth human malaria parasite.
2008,
Pubmed